{"id":58521,"date":"2024-08-21T12:04:33","date_gmt":"2024-08-21T12:04:33","guid":{"rendered":"https:\/\/english.saigonbiz.com.vn\/2024\/08\/21\/atyr-pharma-to-participate-in-september-investor-conferences\/"},"modified":"2024-08-21T12:04:33","modified_gmt":"2024-08-21T12:04:33","slug":"atyr-pharma-to-participate-in-september-investor-conferences","status":"publish","type":"post","link":"https:\/\/english.saigonbiz.com\/vn\/atyr-pharma-to-participate-in-september-investor-conferences\/","title":{"rendered":"aTyr Pharma to Participate in September Investor Conferences"},"content":{"rendered":"<div>\n<p align=\"justify\">SAN DIEGO, Aug.  21, 2024  (GLOBE NEWSWIRE) &#8212; aTyr Pharma, Inc. (Nasdaq: ATYR), a clinical stage biotechnology company engaged in the discovery and development of first-in-class medicines from its proprietary tRNA synthetase platform, today announced that the company will participate in several upcoming investor conferences scheduled to take place in September 2024.<\/p>\n<p align=\"justify\">Details of the conferences appear below:<\/p>\n<p>Conference: Wells Fargo Healthcare Conference<br \/>Date: Thursday, September 5, 2024 <br \/>Location: Everett, MA<br \/>Format: 1&#215;1 Investor Meetings<\/p>\n<p>Conference: H.C. Wainwright 26<sup>th<\/sup> Annual Global Investment Conference <br \/>Date: Wednesday, September 11, 2024<br \/>Time: 10:30am EDT<br \/>Location: New York, NY<br \/>Format: Corporate Presentation<\/p>\n<p>Conference: Cantor Fitzgerald Global Healthcare Conference <br \/>Date: Wednesday, September 18, 2024<br \/>Time: 1:55pm EDT<br \/>Location: New York, NY<br \/>Format: Corporate Presentation<\/p>\n<p align=\"justify\">In addition to the presentations, company management will be available to participate in one-on-one meetings with investors who are registered attendees of the conferences. A webcast of the H.C. Wainwright and Cantor Fitzgerald presentations will be available on the Investor\u2019s section of the company\u2019s website at <a href=\"https:\/\/www.globenewswire.com\/Tracker?data=cfz9kheQsZJ6ZfoCQZE1Vyxt0pzjL6mOCYn_04PMdfLZL15VTVZV8YSduN_R5Pi-4Re1js_LPmtH7NtTmkJJV6zRSFqiSh2uXanMHFsqr2Q=\" rel=\"nofollow noopener\" target=\"_blank\" title=\"www.atyrpharma.com\">www.atyrpharma.com<\/a>. Following the events, a replay of the presentations will be available on the aTyr website for at least 90 days. For more information, contact <a href=\"https:\/\/www.globenewswire.com\/Tracker?data=dCaeIGWZAVPZTHKV0qDethlLC1HjtJ3MGkoWwsZ9aZa0w6cUN8-ipP5EthOtipd6P4oAmk_W87oadEO7MGP2baGcACNStGhiyLkgOp7fIgLqY-kPPQHDmOObosLyWq2d\" rel=\"nofollow noopener\" target=\"_blank\" title=\"investorrelations@atyrpharma.com\">investorrelations@atyrpharma.com<\/a>.<\/p>\n<p align=\"justify\"><strong>Abo<\/strong><strong>ut aTyr<\/strong><\/p>\n<p align=\"justify\">aTyr is a clinical stage biotechnology company leveraging evolutionary intelligence to translate tRNA synthetase biology into new therapies for fibrosis and inflammation. tRNA synthetases are ancient, essential proteins that have evolved novel domains that regulate diverse pathways extracellularly in humans. aTyr\u2019s discovery platform is focused on unlocking hidden therapeutic intervention points by uncovering signaling pathways driven by its proprietary library of domains derived from all 20 tRNA synthetases. aTyr\u2019s lead therapeutic candidate is efzofitimod, a first-in-class biologic immunomodulator in clinical development for the treatment of interstitial lung disease, a group of immune-mediated disorders that can cause inflammation and progressive fibrosis, or scarring, of the lungs. For more information, please visit <a href=\"https:\/\/www.globenewswire.com\/Tracker?data=cfz9kheQsZJ6ZfoCQZE1V46ry7hwQ55VowJQxGGg4Hp-K4-vlw86MtKtVT3UTRtYNPgrEIfDPhFFRsMcQaAdgVVVx4JngMLNTIAxXin74EY=\" rel=\"nofollow noopener\" target=\"_blank\" title=\"www.atyrpharma.com\">www.atyrpharma.com<\/a>.<\/p>\n<table align=\"center\" style=\"border-collapse: collapse; width:100%; border-collapse:collapse ;\">\n<tr>\n<td style=\"text-align: justify ;  vertical-align: middle; vertical-align: top ; \"><strong>Contact:<\/strong><\/td>\n<\/tr>\n<tr>\n<td style=\"text-align: justify ;  vertical-align: middle; vertical-align: top ; \">Ashlee Dunston<\/td>\n<\/tr>\n<tr>\n<td style=\"vertical-align: top ; \">Director, Investor Relations and Public Affairs<\/td>\n<\/tr>\n<tr>\n<td style=\"text-align: justify ;  vertical-align: middle; vertical-align: top ; \"><a href=\"mailto:adunston@atyrpharma.com\" rel=\"nofollow noopener\" target=\"_blank\" title=\"\"><u>adunston@atyrpharma.com<\/u><\/a><\/td>\n<\/tr>\n<tr>\n<td style=\"text-align: justify ;  vertical-align: middle; vertical-align: top ; \">\u00a0<\/td>\n<\/tr>\n<\/table>\n<p><img decoding=\"async\" src=\"https:\/\/ml.globenewswire.com\/media\/NjU5MWRhODktMWE1MS00M2M3LWFiOGItODVlMDBkNDE5MTMxLTEwMjkxNDI=\/tiny\/aTyr-Pharma-Inc-.png\" referrerpolicy=\"no-referrer-when-downgrade\"><\/div>\n","protected":false},"excerpt":{"rendered":"<p>SAN DIEGO, Aug. 21, 2024 (GLOBE NEWSWIRE) &#8212; aTyr Pharma, Inc. (Nasdaq: ATYR), a clinical stage biotechnology company engaged in the discovery and development of first-in-class medicines from its proprietary tRNA synthetase platform, today announced that the company will participate in several upcoming investor conferences scheduled to take place in September 2024. Details of the [&#8230;]\n","protected":false},"author":1,"featured_media":58522,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[1],"tags":[],"class_list":["post-58521","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-pr-newswire"],"yoast_head":"<!-- This site is optimized with the Yoast SEO Premium plugin v21.6 (Yoast SEO v21.6) - https:\/\/yoast.com\/wordpress\/plugins\/seo\/ -->\n<title>aTyr Pharma to Participate in September Investor Conferences - Biz and Live in Saigon<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/english.saigonbiz.com\/vn\/atyr-pharma-to-participate-in-september-investor-conferences\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"aTyr Pharma to Participate in September Investor Conferences\" \/>\n<meta property=\"og:description\" content=\"SAN DIEGO, Aug. 21, 2024 (GLOBE NEWSWIRE) &#8212; aTyr Pharma, Inc. (Nasdaq: ATYR), a clinical stage biotechnology company engaged in the discovery an\" \/>\n<meta property=\"og:url\" content=\"https:\/\/english.saigonbiz.com\/vn\/atyr-pharma-to-participate-in-september-investor-conferences\/\" \/>\n<meta property=\"og:site_name\" content=\"Biz and Live in Saigon\" \/>\n<meta property=\"article:publisher\" content=\"https:\/\/www.facebook.com\/SaigonbizGroup\" \/>\n<meta property=\"article:published_time\" content=\"2024-08-21T12:04:33+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/english.saigonbiz.com\/vn\/wp-content\/uploads\/2024\/08\/aTyr-Pharma-Inc-.png\" \/>\n\t<meta property=\"og:image:width\" content=\"1\" \/>\n\t<meta property=\"og:image:height\" content=\"1\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/png\" \/>\n<meta name=\"author\" content=\"admin\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"admin\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"2 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\/\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\/\/english.saigonbiz.com\/vn\/atyr-pharma-to-participate-in-september-investor-conferences\/#article\",\"isPartOf\":{\"@id\":\"https:\/\/english.saigonbiz.com\/vn\/atyr-pharma-to-participate-in-september-investor-conferences\/\"},\"author\":{\"name\":\"admin\",\"@id\":\"https:\/\/english.saigonbiz.com\/vn\/#\/schema\/person\/267b348e6cf32a66aab33637c2d399a6\"},\"headline\":\"aTyr Pharma to Participate in September Investor Conferences\",\"datePublished\":\"2024-08-21T12:04:33+00:00\",\"dateModified\":\"2024-08-21T12:04:33+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\/\/english.saigonbiz.com\/vn\/atyr-pharma-to-participate-in-september-investor-conferences\/\"},\"wordCount\":320,\"publisher\":{\"@id\":\"https:\/\/english.saigonbiz.com\/vn\/#organization\"},\"articleSection\":[\"Pr Newswire\"],\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\/\/english.saigonbiz.com\/vn\/atyr-pharma-to-participate-in-september-investor-conferences\/\",\"url\":\"https:\/\/english.saigonbiz.com\/vn\/atyr-pharma-to-participate-in-september-investor-conferences\/\",\"name\":\"aTyr Pharma to Participate in September Investor Conferences - Biz and Live in Saigon\",\"isPartOf\":{\"@id\":\"https:\/\/english.saigonbiz.com\/vn\/#website\"},\"datePublished\":\"2024-08-21T12:04:33+00:00\",\"dateModified\":\"2024-08-21T12:04:33+00:00\",\"breadcrumb\":{\"@id\":\"https:\/\/english.saigonbiz.com\/vn\/atyr-pharma-to-participate-in-september-investor-conferences\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\/\/english.saigonbiz.com\/vn\/atyr-pharma-to-participate-in-september-investor-conferences\/\"]}]},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\/\/english.saigonbiz.com\/vn\/atyr-pharma-to-participate-in-september-investor-conferences\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\/\/english.saigonbiz.com\/vn\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"aTyr Pharma to Participate in September Investor Conferences\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\/\/english.saigonbiz.com\/vn\/#website\",\"url\":\"https:\/\/english.saigonbiz.com\/vn\/\",\"name\":\"Biz and Live in Saigon\",\"description\":\"\",\"publisher\":{\"@id\":\"https:\/\/english.saigonbiz.com\/vn\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\/\/english.saigonbiz.com\/vn\/?s={search_term_string}\"},\"query-input\":\"required name=search_term_string\"}],\"inLanguage\":\"en-US\"},{\"@type\":\"Organization\",\"@id\":\"https:\/\/english.saigonbiz.com\/vn\/#organization\",\"name\":\"SaigonBiz Media\",\"url\":\"https:\/\/english.saigonbiz.com\/vn\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\/\/english.saigonbiz.com\/vn\/#\/schema\/logo\/image\/\",\"url\":\"https:\/\/english.saigonbiz.com\/vn\/wp-content\/uploads\/2026\/03\/cropped-c2adea16-1c71-4315-8801-803a8d237e2a_removalai_preview.png\",\"contentUrl\":\"https:\/\/english.saigonbiz.com\/vn\/wp-content\/uploads\/2026\/03\/cropped-c2adea16-1c71-4315-8801-803a8d237e2a_removalai_preview.png\",\"width\":512,\"height\":512,\"caption\":\"SaigonBiz Media\"},\"image\":{\"@id\":\"https:\/\/english.saigonbiz.com\/vn\/#\/schema\/logo\/image\/\"},\"sameAs\":[\"https:\/\/www.facebook.com\/SaigonbizGroup\"]},{\"@type\":\"Person\",\"@id\":\"https:\/\/english.saigonbiz.com\/vn\/#\/schema\/person\/267b348e6cf32a66aab33637c2d399a6\",\"name\":\"admin\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\/\/english.saigonbiz.com\/vn\/#\/schema\/person\/image\/\",\"url\":\"https:\/\/english.saigonbiz.com\/vn\/wp-content\/uploads\/2026\/03\/c2adea16-1c71-4315-8801-803a8d237e2a_removalai_preview-2_uwp_avatar_thumb.png\",\"contentUrl\":\"https:\/\/english.saigonbiz.com\/vn\/wp-content\/uploads\/2026\/03\/c2adea16-1c71-4315-8801-803a8d237e2a_removalai_preview-2_uwp_avatar_thumb.png\",\"caption\":\"admin\"},\"sameAs\":[\"https:\/\/english.saigonbiz.com\/vn\"],\"url\":\"https:\/\/english.saigonbiz.com\/vn\/profile\/admin\/\"}]}<\/script>\n<!-- \/ Yoast SEO Premium plugin. -->","yoast_head_json":{"title":"aTyr Pharma to Participate in September Investor Conferences - Biz and Live in Saigon","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/english.saigonbiz.com\/vn\/atyr-pharma-to-participate-in-september-investor-conferences\/","og_locale":"en_US","og_type":"article","og_title":"aTyr Pharma to Participate in September Investor Conferences","og_description":"SAN DIEGO, Aug. 21, 2024 (GLOBE NEWSWIRE) &#8212; aTyr Pharma, Inc. (Nasdaq: ATYR), a clinical stage biotechnology company engaged in the discovery an","og_url":"https:\/\/english.saigonbiz.com\/vn\/atyr-pharma-to-participate-in-september-investor-conferences\/","og_site_name":"Biz and Live in Saigon","article_publisher":"https:\/\/www.facebook.com\/SaigonbizGroup","article_published_time":"2024-08-21T12:04:33+00:00","og_image":[{"width":1,"height":1,"url":"https:\/\/english.saigonbiz.com\/vn\/wp-content\/uploads\/2024\/08\/aTyr-Pharma-Inc-.png","type":"image\/png"}],"author":"admin","twitter_card":"summary_large_image","twitter_misc":{"Written by":"admin","Est. reading time":"2 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/english.saigonbiz.com\/vn\/atyr-pharma-to-participate-in-september-investor-conferences\/#article","isPartOf":{"@id":"https:\/\/english.saigonbiz.com\/vn\/atyr-pharma-to-participate-in-september-investor-conferences\/"},"author":{"name":"admin","@id":"https:\/\/english.saigonbiz.com\/vn\/#\/schema\/person\/267b348e6cf32a66aab33637c2d399a6"},"headline":"aTyr Pharma to Participate in September Investor Conferences","datePublished":"2024-08-21T12:04:33+00:00","dateModified":"2024-08-21T12:04:33+00:00","mainEntityOfPage":{"@id":"https:\/\/english.saigonbiz.com\/vn\/atyr-pharma-to-participate-in-september-investor-conferences\/"},"wordCount":320,"publisher":{"@id":"https:\/\/english.saigonbiz.com\/vn\/#organization"},"articleSection":["Pr Newswire"],"inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/english.saigonbiz.com\/vn\/atyr-pharma-to-participate-in-september-investor-conferences\/","url":"https:\/\/english.saigonbiz.com\/vn\/atyr-pharma-to-participate-in-september-investor-conferences\/","name":"aTyr Pharma to Participate in September Investor Conferences - Biz and Live in Saigon","isPartOf":{"@id":"https:\/\/english.saigonbiz.com\/vn\/#website"},"datePublished":"2024-08-21T12:04:33+00:00","dateModified":"2024-08-21T12:04:33+00:00","breadcrumb":{"@id":"https:\/\/english.saigonbiz.com\/vn\/atyr-pharma-to-participate-in-september-investor-conferences\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/english.saigonbiz.com\/vn\/atyr-pharma-to-participate-in-september-investor-conferences\/"]}]},{"@type":"BreadcrumbList","@id":"https:\/\/english.saigonbiz.com\/vn\/atyr-pharma-to-participate-in-september-investor-conferences\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/english.saigonbiz.com\/vn\/"},{"@type":"ListItem","position":2,"name":"aTyr Pharma to Participate in September Investor Conferences"}]},{"@type":"WebSite","@id":"https:\/\/english.saigonbiz.com\/vn\/#website","url":"https:\/\/english.saigonbiz.com\/vn\/","name":"Biz and Live in Saigon","description":"","publisher":{"@id":"https:\/\/english.saigonbiz.com\/vn\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/english.saigonbiz.com\/vn\/?s={search_term_string}"},"query-input":"required name=search_term_string"}],"inLanguage":"en-US"},{"@type":"Organization","@id":"https:\/\/english.saigonbiz.com\/vn\/#organization","name":"SaigonBiz Media","url":"https:\/\/english.saigonbiz.com\/vn\/","logo":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/english.saigonbiz.com\/vn\/#\/schema\/logo\/image\/","url":"https:\/\/english.saigonbiz.com\/vn\/wp-content\/uploads\/2026\/03\/cropped-c2adea16-1c71-4315-8801-803a8d237e2a_removalai_preview.png","contentUrl":"https:\/\/english.saigonbiz.com\/vn\/wp-content\/uploads\/2026\/03\/cropped-c2adea16-1c71-4315-8801-803a8d237e2a_removalai_preview.png","width":512,"height":512,"caption":"SaigonBiz Media"},"image":{"@id":"https:\/\/english.saigonbiz.com\/vn\/#\/schema\/logo\/image\/"},"sameAs":["https:\/\/www.facebook.com\/SaigonbizGroup"]},{"@type":"Person","@id":"https:\/\/english.saigonbiz.com\/vn\/#\/schema\/person\/267b348e6cf32a66aab33637c2d399a6","name":"admin","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/english.saigonbiz.com\/vn\/#\/schema\/person\/image\/","url":"https:\/\/english.saigonbiz.com\/vn\/wp-content\/uploads\/2026\/03\/c2adea16-1c71-4315-8801-803a8d237e2a_removalai_preview-2_uwp_avatar_thumb.png","contentUrl":"https:\/\/english.saigonbiz.com\/vn\/wp-content\/uploads\/2026\/03\/c2adea16-1c71-4315-8801-803a8d237e2a_removalai_preview-2_uwp_avatar_thumb.png","caption":"admin"},"sameAs":["https:\/\/english.saigonbiz.com\/vn"],"url":"https:\/\/english.saigonbiz.com\/vn\/profile\/admin\/"}]}},"_links":{"self":[{"href":"https:\/\/english.saigonbiz.com\/vn\/wp-json\/wp\/v2\/posts\/58521","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/english.saigonbiz.com\/vn\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/english.saigonbiz.com\/vn\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/english.saigonbiz.com\/vn\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/english.saigonbiz.com\/vn\/wp-json\/wp\/v2\/comments?post=58521"}],"version-history":[{"count":0,"href":"https:\/\/english.saigonbiz.com\/vn\/wp-json\/wp\/v2\/posts\/58521\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/english.saigonbiz.com\/vn\/wp-json\/wp\/v2\/media\/58522"}],"wp:attachment":[{"href":"https:\/\/english.saigonbiz.com\/vn\/wp-json\/wp\/v2\/media?parent=58521"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/english.saigonbiz.com\/vn\/wp-json\/wp\/v2\/categories?post=58521"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/english.saigonbiz.com\/vn\/wp-json\/wp\/v2\/tags?post=58521"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}